Connor Clark & Lunn Investment Management Ltd. Purchases 115,901 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
Connor Clark & Lunn Investment Management Ltd. lifted its position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 50.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 345,039 shares of the company’s stock after acquiring an additional 115,901 shares during the quarter. […]
